New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
08:58 EDTSNTA, PNT, PPHMThree pharma companies have good partnering prospects, says Roth Capital
Roth Capital believes that Peregrine (PPHM), Palatin (PTN), and Synta (SNTA) have good odds of signing partnership deals in the "relative near term." The firm keeps Buy ratings on all three stocks.
News For PPHM;PNT;SNTA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 13, 2015
17:19 EDTPPHMPeregrine to highlight Bavituximab at ASCO annual meeting
Peregrine Pharmaceuticals, a biopharmaceutical company focused on advancing bavituximab, a novel immuno-oncology agent in Phase III development, announced the presentation of three posters at the 2015 American Society of Clinical Oncology, ASCO, Annual Meeting, to be held May 29-June 2 in Chicago, Illinois.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use